The Division of Cardiology is at the forefront of cardiovascular research, encompassing a wide range of areas, including advanced imaging techniques, electrophysiology, interventional cardiology, and the development of new therapeutic strategies. By integrating clinical expertise with cutting-edge technology, we aim to improve patient outcomes and contribute to the global understanding of cardiovascular health. Our commitment to research excellence ensures that we remain leaders in the field, continually pushing the boundaries of what is possible in cardiology.
N/A
Research interests include the epidemiology, diagnosis and management of heart failure and valvular heart disease, device and technique innovation in structural heart interventions, application of big data analysis and artificial intelligence in structural heart disease and heart failure, cardiogenic shock and mechanical circulatory support.
Selected Publications:
Research interests focus on the advanced management and ablation of arrhythmias, including atrial fibrillation, ventricular tachycardia, and supraventricular tachycardia. These conditions, characterized by irregular heart rhythms, require precise and innovative treatment strategies to improve patient outcomes. Additionally, our work in device implantation emphasizes cutting-edge technologies such as leadless pacemakers and conduction system pacing. These devices represent significant advancements in cardiac care, offering less invasive options and improved synchronization of the heart’s electrical activity. The research aims to enhance the efficacy and safety of these interventions, ultimately contributing to better cardiovascular health.
Selected Publications:
Research interests cover a wide range of cardiovascular and peripheral vascular diseases, focusing on awareness and management. For cardiovascular disease, emphasizing on raising awareness of risk factors, controlling them, and using lipid-lowering therapies to prevent mortality. For peripheral vascular disease, the research includes diagnosis, evaluation, epidemiology, and management trends in Hong Kong, using both pharmacological and nonpharmacological treatments. Interests extend to transcatheter endovascular interventions for thromboembolism, critical limb ischemia, chronic thromboembolic pulmonary hypertension, and malignant pericardial effusion. Finally, clinical epidemiology and outcome research examine the impact of COVID-19 on medical outpatient visits.
Selected Publications:
Research interests encompass a diverse and impactful range of topics within cardiovascular medicine and health economics. We focus on percutaneous coronary and endovascular interventions, which are minimally invasive procedures aimed at treating coronary artery disease and other vascular conditions. Additionally, we explore peripheral arterial disease, a common circulatory problem where narrowed arteries reduce blood flow to the limbs. Our interest in atrial fibrillation involves studying this common heart rhythm disorder to improve patient outcomes and treatment strategies. Finally, our work in health economics examines the cost-effectiveness and economic impact of various healthcare interventions, aiming to optimize resource allocation and improve overall healthcare delivery. This multidisciplinary approach not only advances medical knowledge but also strives to enhance patient care and healthcare efficiency.
Selected Publications:
©Copyright 2024 The Chinese University of Hong Kong. All Rights Reserved.